BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5034245)

  • 1. Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.
    Minderhoud JM; Smith JK
    Clin Exp Immunol; 1972 Apr; 10(4):571-9. PubMed ID: 5034245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 3. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
    Carnegie PR; Caspary EA; Dickinson JP; Field EJ
    Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].
    Zhukhina GE
    Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW; Embeton MJ
    Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
    Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
    Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of antigen-induced electrophoretic mobility reduction of guinea-pig macrophages.
    Caspary EA
    Clin Exp Immunol; 1972 Jun; 11(2):305-9. PubMed ID: 5040311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some aspects of the cellular and humoral immune response to tumour antigens.
    Hellström KE; Hellström I
    Triangle; 1972; 11(1):23-8. PubMed ID: 4624858
    [No Abstract]   [Full Text] [Related]  

  • 14. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte sensitization detected by the macrophage electrophoretic mobility assay in patients with renal cell carcinoma: Theophylline increases the sensitivity of the assay.
    Malkovský M; Bubeník J; Malkovská V; Indrová M; Suhajová E; Jakoubková J; Jíra M
    Arch Geschwulstforsch; 1981; 51(4):364-70. PubMed ID: 7032451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytopherometry in neurologic diseases (author's transl)].
    Meyer-Rienecker HJ; Jenssen HL; Köhler H; Werner H
    Fortschr Neurol Psychiatr Grenzgeb; 1977 Nov; 45(11):615-29. PubMed ID: 336499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen cross-reactivity in the macrophage electrophoretic mobility test. A study using cellular affinity chromatography.
    McDermott JR; Caspary EA; Dickinson JP
    Clin Exp Immunol; 1974 May; 17(1):103-11. PubMed ID: 4143111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
    Nakajima T; Isojima K; Iwaguchi T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation of viable from non-viable tumor cells using Ficoll-Hypaque density solution.
    Mavligit GM; Gutterman JU; Hersh EM
    Immunol Commun; 1973; 2(5):463-72. PubMed ID: 4518928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.